在固体癌症中探索瘤微环境:从生物学到治疗
Zubair Ahmed1, Muneeb Ullah2, Danish Zeshan1
1Department of Pharmacy, Kohat University of Science and Technology, Kohat, Khyber Pakhtunkhwa, Pakistan.
Methods in cell biology
|October 1, 2025
概括
本章探讨了固体癌症中的瘤微环境 (TME),强调其在癌症生物学和治疗策略中的作用. 准TME组件为克服治疗耐药性和改善患者治疗结果提供了未来的潜力.
科学领域:
- 在瘤学瘤学.
- 癌症生物学 癌症生物学
- 免疫学 免疫学 免疫学
背景情况:
- 癌症的特点是无法控制的细胞生长,这带来了复杂的挑战,特别是固体瘤 (85%的恶性瘤).
- 传统的治疗方法,如化疗和放射治疗,面临着包括耐药性和副作用在内的局限性.
- 瘤微环境 (TME),包括癌症和支持细胞,显著影响瘤进展和治疗疗效.
研究的目的:
- 在固体癌症中探索瘤微环境 (TME).
- 阐明TME在癌症生物学和治疗策略中的作用.
- 讨论未来针对TME改善癌症治疗的方向.
主要方法:
- 关于实体瘤生物学和瘤微环境的当前文献的综述.
- 分析TME的细胞和非细胞组成部分.
- 检查针对TME的治疗策略.
主要成果:
- TME包括癌细胞,免疫细胞 (T淋巴细胞,B淋巴细胞,NK细胞,巨细胞),内皮细胞和纤维细胞.
- 这些组成部分以动态相互作用,影响瘤生长,转移和免疫逃避.
- TME的特征,如血管化和间歇性压力,阻碍了药物输送和治疗成功.
结论:
- TME是固体瘤进展和对治疗的反应的关键决定因素.
- 了解TME复杂性对于开发有效的癌症治疗是必不可少的.
- 针对TME组件的未来疗法有望克服耐药性并改善患者的治疗结果.
相关概念视频
02:17The Tumor Microenvironment
7.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K
01:27Tumor Immunotherapy
1.8K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.8K
02:49Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K